Mysteries behind Cervical Cancer Unveiled

.

Mysteries behind Cervical Cancer Unveiled

Previous studies have shown that black women find it hard to overcome cervical cancer. However, a recent study has shed light over the causes which make it difficult for the black women to overcome the cancer.

According to the researchers of the University of South Carolina, black women find it hard to ward off HPV, which is believed to be responsible for triggering cancer. The researchers, for the study, analyzed 326 white and 113 black women.

The participants of the study were asked to go through Pap tests and HPV tests, twice in a year. During the study, the researchers found that as compared to white women, black women find it hard to get rid of the HPV strains.

Because of the presence of HPV, black women become the victim of cervical cancer. The lead researcher of the study, Kim Creek was reported as saying, “The African American women weren't clearing the virus as fast. They were actually holding on to it about six months longer”.

The study was conducted for a period of two years. It is hoped that the findings of the recent study would help in finding effective way of treating cervical cancer and thus women would be saved from being affected by it.


Latest News

South Korean Automaker Kia to Construct a $1 Billion Car Assembly Plant In Mexic
Deal Reached Finally for Market Basket: Ex CEO to Buy the Supermarket Chain
Latest Funding Value Snapchat at $10 billion
American Airlines Pulls Listing and Fares from Orbitz Due to Unsuccessful Effort
Is Burger King’s Deal with Tim Hortons Going to Affect Its Popularity?
Fans Show Twitch’s $970 Million Acquisition is Worth It
Ann Taylor (ANN) Shares Increase as Activist and Investors Put Pressure for Sale
Though The Market Basket Employees are Disappointed But They are not Giving up P
CME Group Faces Technical Glitch that Halts Trading for Four Hours
Survey Shows Lesser Number of Economists Believe US Monetary Policy to be on Rig
Burger King in Discussion with Canada's Tim Hortons for a Merger
Ackman and Valeant call for special meeting of Allergan shareholders